Mechanisms Of Retinal Functional Hyperaemia In Humans With And Without Type 1 Diabetes
Funder
National Health and Medical Research Council
Funding Amount
$117,526.00
Summary
Fenofibrate has been shown to reduce the progression of diabetic retinopathy (DR) in patients with type 2 diabetes by up to 40%, however the mechanisms behind this result are poorly understood. This research will investigate measures of local and systemic endothelial dysfunction and levels of lipids and lipoproteins to determine how fenofibrate affects the progression of DR in patients with type 2 diabetes and in doing so form the basis of further basic and clinical research.